AQR Capital Management - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 215 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$842,129
-88.2%
89,875
-69.0%
0.00%
-86.7%
Q2 2023$7,122,433
-9.4%
290,356
-14.0%
0.02%
-11.8%
Q1 2023$7,857,627
+0.6%
337,672
+9.4%
0.02%
-5.6%
Q4 2022$7,812,514
+14.9%
308,673
-12.5%
0.02%
+5.9%
Q3 2022$6,801,000
+27.3%
352,733
+68.2%
0.02%
+41.7%
Q2 2022$5,341,000
+89.5%
209,709
+91.4%
0.01%
+140.0%
Q1 2022$2,818,000
+582.3%
109,570
+1053.6%
0.01%
+400.0%
Q3 2021$413,000
-33.5%
9,498
-21.6%
0.00%0.0%
Q1 2021$621,000
-16.1%
12,111
-43.8%
0.00%0.0%
Q3 2020$740,00021,5430.00%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q2 2022
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$14,609,16117.42%
SB INVESTMENT ADVISERS (UK) LTD 16,684,041$156,329,4641.29%
Octagon Capital Advisors LP 325,050$3,045,7190.47%
SECTOR GAMMA AS 148,538$1,391,8010.36%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 1,345,635$12,608,6000.31%
ALGERT GLOBAL LLC 449,685$4,2140.20%
Quantamental Technologies LLC 18,519$173,5230.16%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 47,000$439,9200.15%
DUALITY ADVISERS, LP 123,871$1,160,6710.14%
Empowered Funds, LLC 385,135$3,608,7150.11%
View complete list of VIR BIOTECHNOLOGY INC shareholders